Skip to main content

National Healthcare Properties Reports Second Quarter 2025 Results

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the “Company”), a self-managed diversified healthcare real estate investment trust focusing on seniors housing and outpatient medical facilities, today announced results for the three and six months ended June 30, 2025.

Michael Anderson, Chief Executive Officer and President, commented, “We are very pleased with our second quarter results, headlined by exceptional same store cash net operating income growth in each of the Senior Housing Operating Property and Outpatient Medical Facility segments. This across-the-board operational strength demonstrates the capabilities of our team and the quality of our portfolio, providing a tremendous backdrop for the Company as we prepare for an eventual public listing.”

Financial Performance and Other Highlights

  • Net loss of $(0.85) per basic and diluted share. Nareit defined Funds from Operations (“FFO”) of $0.19 per diluted share, and Adjusted Funds from Operations (“AFFO”) of $0.32 per diluted share.
    • FFO per share increased 35.7% on a quarter-over-quarter basis.
    • AFFO per share increased 3.2% on a quarter-over-quarter basis.
  • Second quarter portfolio Same Store Cash Net Operating Income (“NOI”) growth was 8.5% year-over-year.
    • Senior Housing Operating Property (“SHOP”) segment Same Store Cash NOI growth was 17.3%.
    • Outpatient Medical Facility (“OMF”) segment Same Store Cash NOI growth was 4.4%.
  • Second quarter dispositions totaled $21.4 million, representing the sale of three non-core OMFs and three non-core SHOPs.

Operating Update

SHOP Portfolio

  • Year-over-year Same Store Cash NOI growth of 17.3%.
  • Quarter-over-quarter Same Store Cash NOI growth of 6.6%.
  • Same Store average occupancy totaled 82.8%, an increase of 5.0% on a year-over-year basis.
  • Same Store revenue increased 11.8% on a year-over-year basis.
  • Same Store Cash NOI Margin totaled 19.5%, an expansion of 0.9% on a year-over-year basis.

OMF Portfolio

  • Year-over-year Same Store Cash NOI growth of 4.4%.
  • Quarter-over-quarter Same Store Cash NOI growth of 5.7%.
  • Same Store ending occupancy totaled 92.2%, a decrease of 0.7% on a year-over-year basis.

Investment Activity

The Company completed dispositions with an aggregate contract sales price of $21.4 million during the quarter ended June 30, 2025. These dispositions consisted of three OMFs and three SHOPs, with each asset considered to be non-core. A net gain of $2.7 million was recognized as a result of these dispositions.

Balance Sheet and Capital

As of June 30, 2025, total debt outstanding (net of unamortized debt issuance costs) was $1.0 billion with a weighted average interest rate of 5.1% (when giving effect to interest rate hedges) and an average remaining term of 3.7 years.

Year-to-date through June 2025, the Company has paid down $83.1 million of debt using proceeds from dispositions. In April 2025, the Company fully repaid the $21.7 million Capital One OMF Warehouse Facility.

Net Leverage (Net Debt to Annualized Adjusted EBITDA) totaled 9.3x, an improvement of 0.4x relative to March 31, 2025.

Preferred Stock

On June 20, 2025, the Board of Directors declared dividends on the Company’s outstanding preferred stock as follows:

  • A dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock to holders of record at the close of business on July 3, 2025. The dividend was paid on July 15, 2025.
  • A dividend of $0.4453125 per share on its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock to holders of record at the close of business on July 3, 2025. The dividend was paid on July 15, 2025.

During the quarter ended June 30, 2025, the Company completed the repurchase of $1.8 million of previously outstanding shares of preferred stock at a weighted average yield of 12.8%, representing a $10.87 discount to face value and reducing leverage by $1.3 million on a “Net Debt + Preferred” basis.

Supplemental Information

Additional information regarding these results can be found in the Company’s supplemental financial package that will be available on the Investor Relations section of the Company’s website at nhpreit.com.

About National Healthcare Properties

National Healthcare Properties is a self-managed real estate investment trust focusing on seniors housing and outpatient medical facilities. The Company’s preferred stocks are traded on the Nasdaq Exchange under the tickers “NHPAP” and “NHPBP”. Additional information about the Company can be found on its website at nhpreit.com.

Investor & Media Contact

Email: ir@nhpreit.com

Forward-Looking Statements

This press release may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements concern and are based upon, among other things, the possible expansion of the Company’s portfolio; the sale of properties; the performance of its operators/tenants and properties; its ability to enter into agreements with new viable tenants for vacant space on favorable terms, or at all; its occupancy rates; its ability to acquire, develop and/or manage properties; its ability to make distributions to shareholders; its policies and plans regarding investments, financings and other matters; its tax status as a real estate investment trust; its critical accounting policies; its ability to appropriately balance the use of debt and equity; its ability to access capital markets or other sources of funds; and its ability to finance and complete, and the effect of, future acquisitions. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The Company’s expected results may not be achieved, and actual results may differ materially from expectations. This may be a result of various factors, including, but not limited, the risks and uncertainties described in the section titled Risk Factors of its most recent Annual Report on Form 10-K for the year ended December 31, 2024 and all other filings with the Securities and Exchange Commission. Finally, the Company assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.

Financial Statements and Definitions

This press release includes certain non-GAAP financial measures, including FFO, AFFO, EBITDA, Adjusted EBITDA, NOI, Cash NOI and Same Store Cash NOI. While the Company believes that non-GAAP financial measures are helpful in evaluating its operating performance, the use of non-GAAP financial measures in this press release should not be considered in isolation from, or as an alternative for, a measure of financial or operating performance as defined by GAAP. There are inherent limitations associated with the use of each of these supplemental non-GAAP financial measures as an analytical tool. Additionally, the Company’s computation of non-GAAP financial measures may not be comparable to those reported by other REITs. Definitions of these non-GAAP financial measures and reconciliations to their most directly comparable GAAP measures are provided below.

Nareit FFO​ and AFFO

The Company calculates FFO consistent with the standards established over time by Nareit. Nareit defines FFO as net income or loss (computed in accordance with GAAP), adjusted for (i) real estate-related depreciation and amortization, (ii) impairment charges on depreciable real property, (iii) gains or losses from sales of depreciable real property and (iv) similar adjustments for non-controlling interests and unconsolidated entities.

The Company calculates AFFO by further adjusting FFO to reflect the performance of its portfolio for items it believes are not directly attributable to its operations. The Company’s adjustments to FFO to arrive at AFFO include removing the impacts of (i) acquisition and transaction related costs, (ii) amortization of market-lease intangible assets and liabilities, (iii) adjustments for straight-line rent, (iv) termination fees to related parties, (v) equity-based compensation expense, (vi) depreciation and amortization related to non-real estate related assets, (vii) mark-to-market gains and losses from its non-designated derivatives, (viii) non-cash components of interest expense, (ix) casualty-related charges, (x) gains or losses on extinguishment of debt and (xi) similar adjustments for non-controlling interests and unconsolidated entities.

The Company considers FFO and AFFO to be useful supplemental measures for reviewing comparative operating and financial performance because, by excluding the applicable items listed below, FFO and AFFO can help investors compare its operating performance between periods or as compared to other REITs.

Adjusted EBITDA

The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, excluding acquisition and transaction related costs, termination fees to related parties, interest and other income, amortization of market-lease intangible assets and liabilities and other non-cash items including equity-based compensation, impairment charges, casualty-related charges, gains and losses on sale of real estate investments, gains or losses on extinguishment of debt and gains and losses on derivative investments.​

Cash NOI and NOI ​

The Company defines NOI as total revenues from tenants less property operating costs. The Company defines Cash NOI as NOI excluding net amortization of above/below market lease and lease intangibles and straight-line rent adjustments that are included in GAAP revenue from tenants and property operating and maintenance.​

Cash NOI Margin​

For the SHOP segment, Cash NOI divided by revenue from tenants excluding net amortization of above/below market lease and lease intangibles.​

Net Debt​

Total gross debt less cash and cash equivalents.​

Net Debt to Annualized Adjusted EBITDA or Net Leverage​

Net Debt divided by Annualized Adjusted EBITDA (annualized based on Adjusted EBITDA for the quarter multiplied by four).​

Non-Core Properties​

Assets that have been deemed not essential to generating future economic benefit or value to the Company’s day-to-day operations and/or are scheduled to be sold.​

Occupancy or Leased %​

Occupancy for the OMF segment is presented as of the end of the period shown; occupancy for the SHOP segment is presented for the duration of the period shown.​

Same Store​

The Company defines “same store” as operational properties owned for the full period in both comparison periods and that are not otherwise excluded. Properties are excluded from same store if they are (i) Non-Core Properties (as defined above), (ii) sold, classified as held for sale, or classified as discontinued operations in accordance with GAAP; or (iii) impacted by materially disrupted events. Refer to the reconciliation of Same Store properties below.

 
NATIONAL HEALTHCARE PROPERTIES, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
(Unaudited)
 
 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
ASSETS         
Real estate investments, at cost:         
Land$177,999  $182,662  $190,082  $198,124  $208,522 
Buildings, fixtures and improvements 1,804,274   1,837,150   2,012,401   2,051,313   2,131,409 
Acquired intangible assets 249,941   256,440   284,447   290,408   294,683 
Construction in progress 4,126   9,558   7,867   3,930   4,967 
Total real estate investments, at cost 2,236,340   2,285,810   2,494,797   2,543,775   2,639,581 
Less: accumulated depreciation and amortization (671,070)  (670,907)  (725,831)  (724,985)  (720,254)
Total real estate investments, net 1,565,270   1,614,903   1,768,966   1,818,790   1,919,327 
Assets held for sale 1,725             
Cash and cash equivalents 47,123   71,383   21,652   32,858   29,461 
Restricted cash 56,047   55,025   52,443   52,054   51,512 
Derivative assets, at fair value 11,208   13,281   19,206   17,177   31,568 
Straight-line rent receivable, net 20,315   19,967   22,841   23,056   26,171 
Operating lease right-of-use assets 6,841   6,879   7,480   7,553   7,587 
Prepaid expenses and other assets 22,591   23,721   26,316   23,706   25,870 
Accounts receivable, net 9,311   8,096   5,850   5,238   4,967 
Deferred costs, net 18,465   18,630   21,269   17,238   16,916 
Total assets 1,758,896   1,831,885   1,946,023   1,997,670   2,113,379 
LIABILITIES AND EQUITY         
Mortgage notes payable, net$696,508  $711,065  $779,160  $816,988  $816,757 
Credit facilities 337,624   360,774   362,216   363,659   365,101 
Market lease intangible liabilities, net 5,380   5,691   6,125   6,910   7,211 
Derivative liabilities, at fair value              
Accounts payable and accrued expenses 46,322   54,649   89,575   84,472   143,620 
Operating lease liabilities 7,801   7,815   8,109   8,122   8,133 
Deferred rent 9,347   8,275   7,217   5,717   6,474 
Distributions payable 3,432   3,496   3,496   3,496   3,496 
Total liabilities 1,106,414   1,151,765   1,255,898   1,289,364   1,350,792 
Stockholders’ Equity         
7.375% Series A cumulative redeemable perpetual preferred stock, $0.01 par value, 4,740,000 authorized 40   40   40   40   40 
7.125% Series B cumulative redeemable perpetual preferred stock, $0.01 par value, 3,680,000 authorized 35   36   36   36   36 
Common stock, $0.01 par value, 300,000,000 shares authorized 1,132   1,132   1,132   1,132   1,132 
Additional paid-in capital 2,532,585   2,533,737   2,533,706   2,533,697   2,533,484 
Accumulated other comprehensive income 9,441   11,646   16,640   14,301   24,468 
Distributions in excess of accumulated earnings (1,896,200)  (1,872,012)  (1,866,994)  (1,846,558)  (1,802,415)
Total stockholders’ equity 647,033   674,579   684,560   702,648   756,745 
Non-controlling interests 5,449   5,541   5,565   5,658   5,842 
Total equity 652,482   680,120   690,125   708,306   762,587 
Total liabilities and equity$1,758,896  $1,831,885  $1,946,023  $1,997,670  $2,113,379 
 

NATIONAL HEALTHCARE PROPERTIES, INC.
CONSOLIDATED INCOME STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
 
 Three Months Ended
 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
          
Revenue from tenants$85,332  $86,443  $87,738  $88,940  $88,817 
          
Operating expenses:         
Property operating and maintenance 53,848   57,540   54,591   56,407   55,005 
Impairment charges 15,212   11,899   13,383   8,829   2,409 
Operating fees to related parties       22   6,391   6,424 
Termination fees to related parties          8,409   98,241 
Acquisition and transaction related 497   51   2,263   5,187   357 
General and administrative 5,406   5,212   5,806   5,502   4,668 
Depreciation and amortization 18,539   23,706   20,681   20,720   21,928 
Total expenses 93,502   98,408   96,746   111,445   189,032 
Operating loss before gain on sale of real estate investments (8,170)  (11,965)  (9,008)  (22,505)  (100,215)
Gain (loss) on sale of real estate investments 2,652   24,989   7,953   1,579   (225)
Operating (loss)/income (5,518)  13,024   (1,055)  (20,926)  (100,440)
Other income (expense):         
Interest expense (15,836)  (14,529)  (17,305)  (18,007)  (17,752)
Interest and other income (expense) 231   (15)  (26)  548   457 
Gain on extinguishment of debt 257      392       
Gain (loss) on non-designated derivatives 32   (1)  1,095   (2,384)  882 
Total other expenses, net (15,316)  (14,545)  (15,844)  (19,843)  (16,413)
Loss before income taxes (20,834)  (1,521)  (16,899)  (40,769)  (116,853)
Income tax expense (benefit)    6   (127)     (65)
Net loss (20,834)  (1,515)  (17,026)  (40,769)  (116,918)
Net loss (income) attributable to non-controlling interests 31   (54)  38   77   452 
Allocation for preferred stock (3,386)  (3,450)  (3,449)  (3,450)  (3,450)
Net loss attributable to common stockholders (24,189)  (5,019)  (20,437)  (44,142)  (119,916)
          
Other comprehensive loss:         
Unrealized (loss) gain on designated derivatives (2,205)  (4,994)  2,339   (10,167)  (1,276)
Comprehensive loss attributable to common stockholders$(26,394) $(10,013) $(18,098) $(54,309) $(121,192)
          
Weighted-average shares outstanding — Basic and Diluted 28,296,439   28,296,439   28,296,439   28,291,594   28,296,439 
Net loss per share attributable to common stockholders — Basic and Diluted$(0.85) $(0.18) $(0.72) $(1.56) $(4.24)
 

NATIONAL HEALTHCARE PROPERTIES, INC.
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(In thousands, except share and per share data)
(Unaudited)
 
  Three Months Ended
  Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
OMFs:          
Revenue from tenants $29,252  $30,635  $33,744  $34,303  $34,671 
Property operating and maintenance  (8,013)  (11,169)  (9,118)  (10,656)  (9,727)
OMF Segment Net Operating Income $21,239  $19,466  $24,626  $23,647  $24,944 
SHOPs:          
Revenue from tenants $56,080  $55,808  $53,994  $54,637  $54,146 
Property operating and maintenance  (45,835)  (46,371)  (45,473)  (45,751)  (45,278)
SHOP Segment Net Operating Income $10,245  $9,437  $8,521  $8,886  $8,868 
Net Operating Income (NOI) $31,484  $28,903  $33,147  $32,533  $33,812 
Impairment charges  (15,212)  (11,899)  (13,383)  (8,829)  (2,409)
Operating fees to related parties        (22)  (6,391)  (6,424)
Termination fees to related parties           (8,409)  (98,241)
Acquisition and transaction related  (497)  (51)  (2,263)  (5,187)  (357)
General and administrative  (5,406)  (5,212)  (5,806)  (5,502)  (4,668)
Depreciation and amortization  (18,539)  (23,706)  (20,681)  (20,720)  (21,928)
Gain (loss) on sale of real estate investments  2,652   24,989   7,953   1,579   (225)
Interest expense  (15,836)  (14,529)  (17,305)  (18,007)  (17,752)
Interest and other income (expense)  231   (15)  (26)  548   457 
Gain (loss) on non-designated derivatives  32   (1)  1,095   (2,384)  882 
Gain (loss) on extinguishment of debt  257      392       
Income tax (expense) benefit     6   (127)     (65)
Net loss (income) attributable to non-controlling interests  31   (54)  38   77   452 
Preferred stock dividends  (3,386)  (3,450)  (3,449)  (3,450)  (3,450)
Net loss attributable to common stockholders (in accordance with GAAP) $(24,189) $(5,019) $(20,437) $(44,142) $(119,916)
 

NATIONAL HEALTHCARE PROPERTIES, INC.
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(In thousands, except share and per share data)
(Unaudited)
 
 Three Months Ended
 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
Net loss attributable to common stockholders (in accordance with GAAP)$(24,189) $(5,019) $(20,437) $(44,142) $(119,916)
Depreciation and amortization on real estate assets 17,127   22,281   19,287   19,293   20,903 
Impairment charges 15,212   11,899   13,383   8,829   2,409 
(Gain) loss on sale of real estate (2,652)  (24,989)  (7,953)  (1,579)  225 
Adjustments for non-controlling interests (146)  (56)  (181)  (64)  (120)
FFO (as defined by NAREIT) attributable to common stockholders 5,352   4,116   4,099   (17,663)  (96,499)
Amortization (accretion) of market lease and other intangibles, net (135)  2,331   (606)  (134)  (228)
Straight-line rent adjustments (635)  (1,023)  (434)  (458)  (90)
Acquisition and transaction related(1) 497   51   2,263   5,187   357 
Termination fees to related parties(2)          8,409   98,241 
Equity-based compensation 570         153   230 
Depreciation and amortization on non-real estate assets 1,411   1,425   1,394   1,427   1,025 
Mark-to-market (gains)/losses from derivatives(3) 813   931   310   4,224   910 
Non-cash components of interest expense(4) 1,481   858   879   880   862 
Adjustments for non-controlling interests(1) (13)  (19)     (91)  (451)
Gain on extinguishment of debt (257)     (392)      
Casualty-related charges(5) 7   115   412   2   17 
Adjusted funds from operations (AFFO) attributable to common stockholders$9,091  $8,785  $7,925  $1,936  $4,374 
Percentage increase Q2’25 vs Q1’25 3.5%        
Percentage increase Q2’25 vs Q2’24 107.8%        
Recurring Capital Expenditures$10,571  $6,658  $10,570  $5,917  $7,281 
          
FFO and AFFO weighted-average shares outstanding — Diluted 28,533,395   28,530,465   28,530,264   28,525,620   28,543,571 
FFO per common share — Diluted$0.19  $0.14  $0.14  $(0.62) $(3.38)
AFFO per common share — Diluted$0.32  $0.31  $0.28  $0.07  $0.15 
 

(1) Includes certain advisory, legal, accounting, information technology, tax and other professional expenses and other non-recurring employee transition expenses that were directly related to the Company’s internalization and the reverse stock split.
(2) Represents the closing payments paid in connection with the Company’s internalization.
(3) Presented as total gains or losses from the Company’s non-designated derivatives net of cash received.
(4) Non-cash components of interest expense include (i) deferred financing cost amortization, (ii) mortgage discount and premium amortization and (iii) amortized gains or losses from terminated hedging instruments
(5) Includes labor, supplies and evacuation expenses from natural disasters not covered by insurance.

 
NATIONAL HEALTHCARE PROPERTIES, INC.
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(In thousands, except share and per share data)
(Unaudited)
 
 Three Months Ended
 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
Net loss (in accordance with GAAP)$(20,834) $(1,515) $(17,025) $(40,771) $(116,918)
Interest expense 15,836   14,529   17,305   18,007   17,752 
Income tax expense    (6)  127      65 
Depreciation and amortization 18,539   23,706   20,681   20,720   21,928 
EBITDA 13,541   36,714   21,088   (2,044)  (77,173)
Acquisition and transaction related 497   51   2,263   5,187   357 
Termination fees to related parties          8,409   98,241 
Equity-based compensation 570         153   230 
Impairment charges 15,212   11,899   13,383   8,829   2,409 
(Gain)/loss on sale of real estate investments (2,652)  (24,989)  (7,953)  (1,579)  225 
(Gain)/loss on non-designated derivatives (32)  1   (1,095)  2,384   (882)
Gain on extinguishment of debt (257)     (392)      
Amortization (accretion) of market lease and other intangibles, net (135)  2,331   (606)  (135)  (228)
Casualty-related charges 7   115   412   2   17 
Adjusted EBITDA 26,751   26,122   27,100   21,206   23,196 
Operating fees to related parties       22   6,391   6,424 
General and administrative 4,836   5,212   5,806   5,349   4,438 
Interest and Other income (231)  15   25   (546)  (457)
Amortization (accretion) of market lease and other intangibles, net 135   (2,331)  606   135   228 
Casualty-related charges (7)  (115)  (412)  (2)  (17)
NOI 31,484   28,903   33,147   32,533   33,812 
Adjustments for straight-line rent (634)  (1,021)  (435)  (458)  (90)
Accretion of market lease and other intangibles, net (135)  2,331   (605)  (133)  (228)
Cash NOI$30,715  $30,213  $32,107  $31,942  $33,494 
 

NATIONAL HEALTHCARE PROPERTIES, INC.
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(In thousands, except share, per share, and property data)
(Unaudited)
 
 Three Months Ended
 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
OMF Segment – Revenue from tenants$29,252  $30,635  $33,744  $34,303  $34,671 
OMF Segment – Property operating and maintenance (8,013)  (11,169)  (9,118)  (10,656)  (9,727)
OMF Segment Net Operating Income$21,239  $19,466  $24,626  $23,647  $24,944 
Straight line rent adjustments (634)  (1,021)  (434)  (456)  (88)
Accretion of market lease and other intangibles, net (165)  2,335   (544)  (135)  (227)
OMF Segment Cash NOI$20,440  $20,780  $23,648  $23,056  $24,629 
Acquisitions              
Dispositions (51)  (1,456)  (3,798  (3,852  (5,070
Non-Core Properties 73   41   44   51   38 
OMF Segment Same Store Cash NOI$20,462  $19,365  $19,894  $19,255  $19,597 
Percentage increase Q2’25 vs Q1’25 5.7%        
Percentage increase Q2’25 vs Q2’24 4.4%        
          

NATIONAL HEALTHCARE PROPERTIES, INC.
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(In thousands, except share and per share data)
(Unaudited)
 
 Three Months Ended
 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
SHOP Segment – Revenue from tenants$56,081  $55,808  $53,994  $54,637  $54,145 
SHOP Segment – Property operating and maintenance (45,836)  (46,371)  (45,472)  (45,751)  (45,279)
SHOP Segment Net Operating Income$10,245  $9,437  $8,522  $8,886  $8,866 
Non-cash adjustments 30   (4)  (63)      
SHOP Segment Cash NOI$10,275  $9,433  $8,459  $8,886  $8,866 
Acquisitions              
Dispositions 455   533   (2  (292  (130
Non-Core Properties 114   207   508   675   508 
SHOP Segment Same Store Cash NOI$10,844  $10,173  $8,965  $9,269  $9,244 
Percentage increase Q2’25 vs Q1’25 6.6%        
Percentage increase Q2’25 vs Q2’24 17.3%        
          

NATIONAL HEALTHCARE PROPERTIES, INC.
NON-GAAP FINANCIAL MEASURES RECONCILIATION
(In thousands, except share, per share, and property data)
(Unaudited)
 
For the three months ended June 30, 2025   
 OMF SHOP
Total properties as of March 31, 2025136  45 
Acquisitions   
Dispositions(3) (3)
    
Total properties as of June 30, 2025133  42 
Non-core properties(1) (2)
Same Store properties as of June 30, 2025132  40 
 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.